COMPOUND WITH CONFIDENCE: PCCA Membership, $795/month.

Pharmacy compounding's source for clinical information, regulatory updates, and opportunities

THE PCCA BLOG

rss

Stay current on PCCA news and events, market trends, and all things compounding!

_BB_Hazardous Spills_800w.jpg

The United States Pharmacopeia (USP) General Chapter 800 addresses the handling of hazardous drugs (HDs) to minimize the risk of exposure to patients, health care workers and the environment. It became compendially applicable in November 2023. USP 800 contains some key elements that specifically apply to employee safety and HD containment. Section 16, for example, discusses managing HD spills and retaining spill kits on site. This article addresses HD spills that occur in a compounding pharmacy; however, it can be adapted for handling of non-HD chemical spills as well.

BB_Designated Person_800w.jpg

Revisions to USP 795, which went into effect November 1, 2023, introduce a new position for compounders: the Designated Person. This person or group of persons are responsible for creating and overseeing training, reviewing compounding staff competencies and maintaining training records for all compounding staff members. In this blog, we review the key responsibilities of the Designated Person for training standards and explore solutions that may help drive greater efficiencies in your compounding pharmacy’s training program.

20240105_BB-USP800_823x462.jpg

On November 1, 2023, revisions to USP Chapter 795 and Chapter 797 became official and made USP 800 compendially applicable and potentially enforceable. However, other regulatory agencies — including state boards of pharmacy and the FDA — may impact whether USP 800 is enforceable in your pharmacy.

202310_USP 795-797_blog_img.jpg

On November 1, 2023, revised USP Chapters 795 and 797 are official. If adopted by your state board of pharmacy, the requirements listed within these Chapters must be met. All PCCA formulations in our formula database now contain updated language and beyond-use dates (BUDs) in compliance with USP Chapters 795 and 797.

202310_Blog_Cleanroom2-Repost_1768x923.jpg

Due to pending USP updates that are effective on November 1, 2023, we’re reposting our January Blog, which reviews how a modular compounding cleanroom can meet evolving regulatory requirements and standards.

202306_BB_USP Chapter 795.png

Read what we’re doing to ensure PCCA Formulas for compounding nonsterile preparations — specifically beyond-use dates — comply with USP Chapter 795 revisions.

How_to_Determine_API_Calculations_in_Pharmacy_Compounding.jpg

PCCA's Matt Martin and Melissa Merrell Rhoads provide guidance and examples to help you determine API calculations in your compounding pharmacy.

202301_Blog_Cleanroom2_1768x923 (1).jpg

A modular compounding cleanroom is a great way to meet evolving regulatory requirements and standards. Learn the basics of a modular cleanroom in the first in a series of articles on Modular Compounding Cleanrooms.

Proposed_Changes_to_USP_797.jpg

Proposed Changes to USP 797

Matt Martin points out the most significant change in the newly proposed version of USP Chapter 797 as well as the cascading effects it has on the guidelines. He also explains the process for the proposed version to become official and what compounding pharmacies and other stakeholders should do about it now.

Proposed_Changes_to_USP_795.jpg

Proposed Changes to USP 795

Matt Martin highlights four key changes in the newly proposed version of USP Chapter 795 that may have significant implications for compounding pharmacies. He also explains what the process will look like for the proposed version to become official and suggests what compounders should do about it now.